Raf kinase activation of adenylyl cyclases: Isoform-selective regulation

Molecular Pharmacology

Volumn 66, Issue 4, 2004, Pages 921-928

  Ding, Qingming ^a   Gros, Robert ^a   Gray, Ian D ^a   Taussig, Ronald ^b   Ferguson, Stephen S G ^a   Feldman, Ross D ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALANINE; FORSKOLIN; ISOENZYME; PHOSPHOTRANSFERASE; RAF PROTEIN; SERINE; VANADIC ACID;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KIDNEY CELL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 4844231725     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.66.4.921     Document Type: Article

References (25)

1. Bol GF, Hulster A, and Pfeuffer T (1997) Adenylyl cyclase type II is stimulated by PKC via C-terminal phosphorylation. Biochim Biophys Acta 1358:307-313.
2. Chen Y, Harry A, Li J, Smit MJ, Bai X, Magnusson R, Pieroni JP, Weng G, and Iyengar R (1997) Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation. Proc Natl Acad Sci USA 94:14100-14104.
3. Cooper DM, Mons N, and Karpen JW (1995) Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature (Lond) 374:421-424.
4. Feldman RD (1993) Insulin-mediated sensitization of adenylyl cyclase activation. Br J Pharmacol 110:1640-1647.
5. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, and Krebs EG (1996) Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem 271:505-511.
6. Hanoune J and Defer N (2001) Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 41:145-174.
7. Heath BM and Terrar DA (1994) Effect of glibenclamide, forskolin, and isoprenaline on the parallel activation of KATP and reduction of IK by cromakalim in cardiac myocytes. Cardiovasc Res 28:818-822.
8. Hindley A and Kolch W (2002) Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J Cell Sci 115:1575-1581.
9. Jap TS, Kwok CF, Wong MC, and Chiang H (1994) The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects. Diabetes Res 27:39-46.
10. Lai HL, Yang TH, Messing RO, Ching YH, Lin SC, and Chern Y (1997) Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response. J Biol Chem 272:4970-4977.
11. Lin TH, Lai HL, Kao YY, Sun CN, Hwang MJ, and Chern Y (2002) Protein kinase C inhibits type VI adenylyl cyclase by phosphorylating the regulatory N domain and two catalytic C1 and C2 domains. J Biol Chem 277:15721-15728.
12. Ludwig MG and Seuwen K (2002) Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms. J Recept Signal Transduct Res 22:79-110.
13. Patel TB, Du Z, Pierre S, Cartin L, and Scholich K (2001) Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene 269:13-25.
14. Pierce KL, Luttrell LM, and Lefkowitz RJ (2001) New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532-1539.
15. Pieroni JP, Harry A, Chen J, Jacobowitz O, Magnusson RP, and Iyengar R (1995) Distinct characteristics of the basal activities of adenylyl cyclases 2 and 6. J Biol Chem 270:21368-21373.
16. Poppleton H, Sun H, Fulgham D, Bertics P, and Patel TB (1996) Activation of Gsα by the epidermal growth factor receptor involves phosphorylation. J Biol Chem 271:6947-6951.
17. Premont RT, Jacobowitz O, and Iyengar R (1992) Lowered responsiveness of the catalyst of adenylyl cyclase to stimulation by GS in heterologous desensitization: a role for adenosine 3′,5′-monophosphate-dependent phosphorylation. Endocrinology 131:2774-2784.
18. Shih M and Malbon CC (1998) Serum and insulin induce a Grb2-dependent shift in agonist affinity of beta-adrenergic receptors. Cell Signal 10:575-582.
19. Tan CM, Kelvin DJ, Litchfield DW, Ferguson SS, and Feldman RD (2001) Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase. Biochemistry 40:1702-1709.
20. Tan CM, McDonald CG, Chorazyczewski J, Burry AF, Feldman RD, and Macdonald CJ (1999) Vanadate stimulation of adenylyl cyclase: an index of tyrosine kinase vascular effects. Clin Pharmacol Ther 66:275-281.
21. Tan CM, Xenoyannis S, and Feldman RD (1995) Oxidant stress enhances adenylyl cyclase activation. Circ Res 77:710-717.
22. Valiquette M, Parent S, Loisel TP, and Bouvier M (1995) Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human beta 2-adrenergic receptor. EMBO (Eur Mol Biol Organ) J 14:5542-5549.
23. Varga EV, Rubenzik M, Grife V, Sugiyama M, Stropova D, Roeske WR, and Yamamura HI (2002) Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation. Eur J Pharmacol 451:101-102.
24. Yoshimura M and Cooper DM (1993) Type-specific stimulation of adenylylcyclase by protein kinase C. J Biol Chem 268:4604-4607.
25. Zimmermann G and Taussig R (1996) Protein kinase C alters the responsiveness of adenylyl cyclases to G protein α and βγ subunits. J Biol Chem 271:27161-27166.